FDA’s Risk Communication Efforts Include Surveying Docs On Adverse Events
Executive Summary
FDA is seeking physicians' input as the agency reviews its efforts to communicate emerging risks in medical products
You may also be interested in...
FDA Closes Gap In Postmarketing Dialog With Physicians Through Online Site
FDA's "evaluation agreement" between its device center and an online forum for health care practitioners is a sign of the agency's growing efforts to reach out to the physician community and improve adverse event reporting
FDA Closes Gap In Postmarketing Dialog With Physicians Through Online Site
FDA's "evaluation agreement" between its device center and an online forum for health care practitioners is a sign of the agency's growing efforts to reach out to the physician community and improve adverse event reporting
Profile Of A Drug Safety Scandal: Avandia Appears Headed Down Familiar Path
With FDA planning an advisory committee review and Congress calling for hearings, the detection of a cardiovascular safety signal for GlaxoSmithKline's type 2 diabetes therapy Avandia has all the hallmarks of a classic drug safety scandal